Allergy/Imm

sponsor

Topics in Allergy/Imm

Allergy/Anaphylaxis

Basic Science/Genetics

Cardiovascular/Pulm

Clinical Pharmacology

Derm Allergy/Immunology

Diagnostics/Radiology

Economics of Medicine

Gastrointestinal/Hepatic

HIV/Immunodeficiency

Hematology/Oncology

Maternal Fetal Medicine

Nephrology/Urology

Neurologic/Ophthalmic

Peds Allergy/Immunology

Rheumatic/Autoimmune

Surgery/Transplantation

Vaccine/Immunotherapy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Top Ten Searches

hla

beta 2

probiotics

hypo allergenic

scid

urticaria

aeroallergens

asthma

angioedema

hiv

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX
Journal of Immunology, 06/30/09

Pawluczkowycz AW et al. - This may facilitate effective capture and concentration of activated complement components closer to the cell membrane, potentially shielding them from inactivation by fluid phase agents and promoting efficient generation of the membrane attack complex.

<< Previous
Efficacy and safety evaluation of ciclesonide in mild-to-moderate...

Next >>
High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune...

Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09

See All of Clinical Pharmacology

Today in Hematology/Oncology...keeping you current

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/23/09

Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer–Specific Immune Responses and Their Correlation to Prognosis
Cancer Research, 11/03/09

T Cell–Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective
Clinical Cancer Research, 10/26/09

See All of Hematology/Oncology

Sponsor

Article Search

Sponsor

Send this Summary to a Colleague